glp 1 and iih Use of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension : a systematic review | The Journal of Headache Pain Management of IIH. The treatment

With such a high discontinuation rate30% within three months and 50% within six months, better support is needed to prevent weight regain, manage side effects and psychological challenges, and build lifestyle changes that are needed for long-term success, whether organizations cover GLP-1s or not

Emerging research suggests some patients using GLP-1 receptor agonists may have inadequate protein intake and occasional sarcopenia, which raises concern about lean mass loss during treatment

FDA News release

For some, the once-weekly injection may be more convenient than daily pills

Proper site rotation not only optimises medication effectiveness but also enhances long-term treatment adherence by minimising discomfort and visible skin changes

Maintain adequate hydration (68 glasses daily), time fluid intake to reduce nighttime urination, keep a symptom diary, review blood glucose control with your healthcare team, and consider pelvic floor exercises if urgency is problematic